CONGRESSIONAL BIOTECHNOLOGY BRIEFING - JUNE 6, 2001 by Millennium Pharmaceuticals, Inc.

  • Contact: Peper Long
    (202) 962-9200
  • Recommend
  • Tweet
  • Print
  • Email

WASHINGTON, D.C. (June 4, 2001) – Millennium Pharmaceuticals, Inc. is conducting a congressional breakfast briefing on biotechnology on June 6, at 8:30 a.m. in Room B-340 of Rayburn House Office Building. Representative Michael E. Capuano (D-MA) is hosting the event.

Millennium Pharmaceuticals Chief Technology Officer Mike Pavia will discuss the biotechnology industry as it relates to medicine and the current health care debate in his briefing entitled “Understanding Biotechnology in Medicine: From Drug Discovery to Development.”

This briefing is scheduled to be the first in a series of congressional briefings on critical issues involving biotechnology, including patenting and licensing, privacy concerns, and cloning.

BIO represents more than 950 biotechnology companies,academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health care, agricultural, industrial and environmental biotechnology products.

# # #

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.